Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Explore blue-chip coin candidates beyond BTC/ETH and how they fit into a balanced, long-term strategy with clear evaluation criteria.
24,967 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
This guide breaks down what to watch in Jackson Financial's 2025 earnings, with practical tips and real-world scenari...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
A solvency crunch threatens Social Security. As the baby-boomer cohort retires, the program could face cuts unless Co...
A leading economist argues that the stock market has drifted away from the pace of everyday economic activity as grow...
Miami’s private enclave on Indian Creek Island has long been the apex of privacy for the ultra-wealthy. As of early 2...
Urban Outfitters posted a strong Q4 2026 with record revenue, led by a rebound in its flagship Urban Outfitters brand...
American Express will relocate its headquarters to the World Trade Center’s final office tower, a milestone in Lower ...
Block reveals a plan to slash thousands of roles with AI tools, but critics warn the move may miss broader shifts in ...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...